NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

download NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

of 37

Transcript of NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    1/37

    NewbornScreening in the

    Philippines (NBS)

    Gelmark S. Olivares, RNNurse Trainee

    Premiere Medical Center

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    2/37

    What is Newborn Screening?

    Newborn Screening (NBS) is a simpleprocedure to find out if the babyhas a congenital metabolic disorderthat may lead to mental retardationand even death if left untreated.

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    3/37

    What is Newborn Screening?

    In most developed countries: An integral part of routine newborn

    careAs routine as Vitamin K injection or CordCare

    In the Philippines: It is now recognized as part of thestandard newborn care

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    4/37

    Why is it important to have

    Newborn Screening?Most babies with metabolicdisorders look normal at birth. Onewill never know that the baby hasthe disorder until the onset of signsand symptoms and more often illeffects are already irreversible.

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    5/37

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    6/37

    How is Newborn Screening

    Performed?

    It involves collection of a few drops of

    blood by heel prick after the first 48 hoursof life

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    7/37

    How is Newborn Screening

    Performed?Blood sample collection(>24 hours of life in term

    newborns)

    Analysis for the presence ofthe disorders screened (NIH

    laboratory)

    NegativePositive

    Confirmatory Test

    Positive

    Appropriate treatment and referrals

    No further

    testing

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    8/37

    Which disorders are screened?

    In the Philippines:Congenital Adrenal Hyperplasia (CAH) 21 hydroxylase deficiencyCongenital Hypothyroidism (CH) Primary Congenital HypothyroidismGalactosemiaPhenylketonuria (PKU)Glucose 6-Phosphate Dehydrogenase(G6PD) deficiency

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    9/37

    CLINICAL MANIFESTATIONS AT BIRTHDI SORDER APPEARANCE AT BI RTH

    CAH Hyperpigmentation

    Ambiguous Genitalia in femaleinfants

    CH Normal

    GAL Normal

    PKU Normal

    G6PD Deficiency Normal

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    10/37

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    11/37

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    12/37

    What is CONGENITAL

    ADRENALHYPERPLASIA?

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    13/37

    CAH, Salt Losing

    Clinical Manifestations Increased pigmentation Ambiguous genitalia in

    female infants

    Poor suck, weak cry Vomiting, excessive

    urination, dehydration Irritability and seizures

    Failure to thrive Hypotension, shock Coma

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    14/37

    Congenital Adrenal Hyperplasia

    Late Manifestations Precocious puberty Skin Puberty:

    pubic hair growth,oily skin, bodyodor"

    Dark skin color Short adult stature

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    15/37

    What is CONGENITAL

    HYPOTHYROIDISM?

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    16/37

    Congenital Hypothyroidism

    Clinical Manifestations Prolonged jaundice Inactive defecation Umbilical Hernia Hypotonia

    Skin: rough and dryPallor, coldness,hypothermia, edema

    Rough facial features Edema, flat nasal bridge,enlarged tongue

    Open fontanelles Delayed overall development

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    17/37

    Congenital Hypothyroidism

    Late Manifestations Mental retardation

    Growth retardation Delayed skeletal

    maturation Delayed dental

    development and tootheruption Delayed puberty

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    18/37

    What is GALACTOSEMIA?

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    19/37

    Galactosemia

    Galactose Component of dietary sugars

    Converted to GLUCOSE for energy storage(glycogen) and energy production

    Galactosemia results from a deficiency of Galactose-1- phosphate uridyltransferase (GALT) Enzyme responsible for converting galactose to

    glucose

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    20/37

    GalactosemiaClinical Manifestations developa few days to two weeks AFTERINITIATION OF MILKFEEDINGS

    Poor suckVomiting, occasionallydiarrheaJaundiceLethargy, weakness, coma

    Septicemia (E. coli)

    Later: excess galactose depositsin tissues

    LiverHepatomegaly

    EdemaAscitesCirrhosis of the liver

    LensCataracts

    BrainMental retardation

    KidneyGrowth failure

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    21/37

    Galactosemia(Baby L)

    at 4 months at 1 year old

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    22/37

    What is

    PHENYLKETONURIA?

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    23/37

    PhenylketonuriaPhenylalanine

    Essential amino acid found in most proteindiets

    TyrosineProduced from phenylalanineComponent of substances that regulate bodyfunctions (hormones/ pigment)

    Inefficient production of tyrosine fromphenylalanine

    Complete absence or profound deficiency ofphenylalanine hydroxylase (PAH) enzymeactivity

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    24/37

    Phenylketonuria

    Very high elevations of blood Phenylalanine Excessive amounts of waste products of

    phenylalanine (phenylketones) in the urineGives the urine a characteristic mousyodor

    Low serum levels of tyrosine

    Disturbance in hormone and pigment production

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    25/37

    PhenylketonuriaClinical Manifestations Vomiting Hyperactivity

    Seizures andhypertonia Musty or mousy urine

    odor Light hair and skin

    color Seborrheic or

    eczematoid rash Mental retardation

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    26/37

    Persistent Benign Hyperphenylalanemia

    (Baby MD)

    at 5 months at 1 year and 10 mos.

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    27/37

    G6PD Deficiency

    Function of G6PD Certain food and drug have oxidant properties

    that causes cell damage In the red blood cells (RBC), the only

    mechanism to neutralize oxidative substances isthrough the G6PD activity

    Without G6PD, RBCs undergoHEMOLYSIS when exposed to oxidativestress!

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    28/37

    OXIDATIVE AGENTS LEADING TO

    HEMOLYSIS IN G6PD DeficiencyDrugsChemicals

    FoodInfection

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    29/37

    CLINICAL MANIFESTIONS OFG6PD Deficiency

    Acute Hemolytic crisisAnemiaDecreased oxygen delivery

    Enlarged spleenIncreased bilirubin

    Jaundice, tea colored urineAccumulation in tissues

    Brain Kernicterus Gall bladder

    Gallstones

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    30/37

    Enactment of the

    Newborn Screening Act of2004

    ( April 6, 2004)

    Signing of the

    Implementing Rules andRegulation of RA 9288

    (October 5, 2004)

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    31/37

    Highlights of RA 9288

    Institutionalize the National NewbornScreening System Section 2

    Ensure that every baby born in thePhilippines is offered the opportunityto undergo NBS

    Defining DOH as the lead agency for the

    implementation of NBS Section 10

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    32/37

    Highlights of RA 9288

    Establishment andaccreditation of theNewborn ScreeningCenters (NSC ) Section 12Establishment of theNewborn ScreeningReference Center(NSRC) Section 13

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    33/37

    Highlights of RA 9288

    Obligation to inform Section 5

    Who will inform? Any health practitioner who delivers,

    or assists in the delivery of a newbornWhat information?

    Availability, nature and benefits of NBS

    Performance of Newborn Screening Section 6

    After 24 hours of life but not later than 3 daysSick neonates in ICU must be tested by the 7 th day oflife

    Regardless of weight and age of gestation

    Wh t i th t f b

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    34/37

    1 bottle of cokeevery week for1 year

    GIVING UP 1.5 sticksevery day for1 year

    2 bottlesevery month

    for 9 months

    2 cell cards in 9months

    Missing 55 daysof

    daily lotto bet

    What is the cost of newbornscreening?

    NewbornScreening FeeP600

    http://www.tanduay.com/image/premiumrum.jpghttp://www.cdf.org/cdf/atissue/vol2_2/cocacola/cokebottle.jpg
  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    35/37

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    36/37

    SAVING 34 000 BABIES A YEARFROM

    MENTAL RETARDATION AND

    DEATH.

  • 8/12/2019 NBS Reporting for PMC-Ward a (Gelmark Olivares, RN)

    37/37

    Thank youforlistening!